3op8: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3op8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3op8 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3op8 RCSB], [http://www.ebi.ac.uk/pdbsum/3op8 PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3op8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3op8 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3op8 RCSB], [http://www.ebi.ac.uk/pdbsum/3op8 PDBsum]</span></td></tr> | ||
</table> | </table> | ||
== Function == | |||
[[http://www.uniprot.org/uniprot/APOH_HUMAN APOH_HUMAN]] Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
